RAM
ABBV icon

Reflection Asset Management’s AbbVie ABBV Stock Holding History

Reflection Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548K Buy
2,519
+502
+25% +$111K 0.34% 70
2025
Q4 		$461K Buy
+2,017
New +$459K 0.33% 65

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Reflection Asset Management's ABBV Position: Q1 2026 in Review

Reflection Asset Management increased its AbbVie (ABBV) stake by 25% in Q1 2026, buying an estimated $111K and bringing the position to 2,519 shares worth $548K. The position accounts for 0.34% of the portfolio, ranked #70.

Reflection Asset Management first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. 4,115 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Reflection Asset Management held 2,519 shares of AbbVie worth $548K as of Q1 2026.
  • Reflection Asset Management bought 502 AbbVie shares in Q1 2026, an estimated $111K.
  • AbbVie made up 0.34% of Reflection Asset Management's portfolio in Q1 2026, its #70 holding.
  • Reflection Asset Management first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • 4,115 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Reflection Asset Management's 13F filing for Q1 2026, filed 26 Aug 2026.